Good Day BIO Newsletter

A busy Thursday on Capitol Hill brought lots of talk about PBMs—we have a recap, plus a look at why we need to invest more in women’s health and R&D. (509 words, 3 minutes, 32 seconds)

BIO President and CEO John F. Crowley lays out the organization’s new strategic direction on national security. Meanwhile, BIO filed an amicus brief in a California lawsuit that could have an impact on drug development. (560 words, 2 minutes, 48 seconds)

More measles cases are being reported across the United States—but why? ICYMI: BIO joined industry commitments for equitable access to medical countermeasures in future pandemics and the EPA approved a BIO member’s novel bioinsecticide. (597 words, 2 minutes, 59 seconds)

Today we tell you what we know about President Biden’s budget (no surprises so far) and unveil the latest episode of the I am BIO Podcast, which unpacks the microbiome hype. (625 words, 3 minutes, 7 seconds)

On Friday, the House passed the Expanding Access to Capital Act (H.R. 2799), which would provide incentives to invest in innovation. We have details, plus how to register for BIO’s first-ever Agriculture and Environment Summit in D.C. (567 words, 2 minutes, 50 seconds)

Happy Friday. We have a look at what Biden said during the SOTU—and BIO’s reaction—and celebrate National Biobased Products Day and Women’s History Month. (634 words, 3 minutes, 10 seconds)

We’re gearing up for the State of the Union, where President Biden’s expected to talk about drug price controls. In the meantime, we review a pandemic preparedness hearing and what U.S. officials are saying about Mexico’s looming corn ban. (626 words, 3 minutes, 7 seconds)

An FDA advisory committee unanimously recommended a change in next year’s flu vaccine and BIO was on the scene when New Mexico Gov. Michelle Lujan Grisham signed the state’s clean fuel standard—plus, an exclusive look at John F. Crowley’s first day as BIO’s CEO. (586 words, 2 minutes, 55 seconds)

We have a quick video recap of yesterday’s White House listening session on PBMs, plus optimism about biotech IPOs and biotech fashion. (678 words, 3 minutes, 23 seconds)

It’s an exciting week, as we officially welcome John Crowley as BIO’s CEO. Meanwhile, we look at what happened at the WTO last week, and what’s ahead at the White House listening session on PBMs today. (623 words, 3 minutes, 6 seconds)